• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GPR40激动剂通过激活AMPK途径改善肝脏X受体诱导的肝脏脂质积累。

GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway.

作者信息

Li Meng, Meng Xiangyu, Xu Jie, Huang Xiuqing, Li Hongxia, Li Guoping, Wang Shu, Man Yong, Tang Weiqing, Li Jian

机构信息

Peking University Fifth School of Clinical Medicine (Beijing Hospital), Beijing, China.

The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics &Beijing Hospital, Ministry of Health, Beijing, China.

出版信息

Sci Rep. 2016 Apr 28;6:25237. doi: 10.1038/srep25237.

DOI:10.1038/srep25237
PMID:27121981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4848522/
Abstract

Hepatic steatosis is strongly linked to insulin resistance and type 2 diabetes. GPR40 is a G protein-coupled receptor mediating free fatty acid-induced insulin secretion and thus plays a beneficial role in the improvement of diabetes. However, the impact of GPR40 agonist on hepatic steatosis still remains to be elucidated. In the present study, we found that activation of GPR40 by its agonist GW9508 attenuated Liver X receptor (LXR)-induced hepatic lipid accumulation. Activation of LXR in the livers of C57BL/6 mice fed a high-cholesterol diet and in HepG2 cells stimulated by chemical agonist caused increased expression of its target lipogenic genes and subsequent lipid accumulation. All these effects of LXR were dramatically downregulated after GW9508 supplementation. Moreover, GPR40 activation was accompanied by upregulation of AMPK pathway, whereas the inhibitive effect of GPR40 on the lipogenic gene expression was largely abrogated by AMPK knockdown. Taken together, our results demonstrated that GW9508 exerts a beneficial effect to ameliorate LXR-induced hepatic steatosis through regulation of AMPK signaling pathway.

摘要

肝脂肪变性与胰岛素抵抗和2型糖尿病密切相关。GPR40是一种G蛋白偶联受体,介导游离脂肪酸诱导的胰岛素分泌,因此在改善糖尿病方面发挥有益作用。然而,GPR40激动剂对肝脂肪变性的影响仍有待阐明。在本研究中,我们发现其激动剂GW9508激活GPR40可减轻肝脏X受体(LXR)诱导的肝脏脂质积累。在喂食高胆固醇饮食的C57BL/6小鼠肝脏中以及在化学激动剂刺激的HepG2细胞中,LXR的激活导致其靶标生脂基因表达增加以及随后的脂质积累。补充GW9508后,LXR的所有这些作用均显著下调。此外,GPR40激活伴随着AMPK途径的上调,而AMPK敲低在很大程度上消除了GPR40对生脂基因表达的抑制作用。综上所述,我们的结果表明,GW9508通过调节AMPK信号通路对改善LXR诱导的肝脂肪变性发挥有益作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/038abb0be29a/srep25237-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/22ebfa884c14/srep25237-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/5fe10f25b53e/srep25237-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/35728fed7bca/srep25237-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/bab4c1303c39/srep25237-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/038abb0be29a/srep25237-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/22ebfa884c14/srep25237-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/5fe10f25b53e/srep25237-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/35728fed7bca/srep25237-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/bab4c1303c39/srep25237-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4542/4848522/038abb0be29a/srep25237-f5.jpg

相似文献

1
GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway.GPR40激动剂通过激活AMPK途径改善肝脏X受体诱导的肝脏脂质积累。
Sci Rep. 2016 Apr 28;6:25237. doi: 10.1038/srep25237.
2
Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in the regulation of glucose homeostasis and insulin sensitivity.选择性 G 蛋白偶联受体 40 激动剂 GW-9508 调节葡萄糖稳态和胰岛素敏感性的多种机制。
Am J Physiol Endocrinol Metab. 2013 Mar 15;304(6):E668-76. doi: 10.1152/ajpendo.00419.2012. Epub 2013 Jan 22.
3
The GPR40 novel agonist SZZ15-11 improves non-alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet-induced obese mice.新型 GPR40 激动剂 SZZ15-11 通过激活 AMPK 通路改善非酒精性脂肪性肝病,并恢复饮食诱导肥胖小鼠的代谢稳态。
Diabetes Obes Metab. 2024 Jun;26(6):2257-2266. doi: 10.1111/dom.15539. Epub 2024 Mar 18.
4
Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway.游离脂肪酸受体1的激活通过一条p38依赖途径改善肝脂肪变性。
J Mol Endocrinol. 2014 Oct;53(2):165-74. doi: 10.1530/JME-14-0003. Epub 2014 Jul 9.
5
Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.大麦芽提取物通过激活肝 AMP 激活的蛋白激酶减少乙醇喂养小鼠的肝脂质积累。
Food Res Int. 2017 Nov;101:209-217. doi: 10.1016/j.foodres.2017.08.068. Epub 2017 Sep 12.
6
Vaccarin ameliorates insulin resistance and steatosis by activating the AMPK signaling pathway.槐定碱通过激活 AMPK 信号通路改善胰岛素抵抗和脂肪变性。
Eur J Pharmacol. 2019 May 15;851:13-24. doi: 10.1016/j.ejphar.2019.02.029. Epub 2019 Feb 16.
7
Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.厚朴酚激活LKB1-AMPK信号通路并减轻肝细胞中的脂质积累。
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):113-24. doi: 10.1016/j.taap.2015.02.020. Epub 2015 Feb 28.
8
Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.单磷酸腺苷激活的蛋白激酶-p70核糖体S6激酶-1通路在一类新型二硫代硫酮抑制肝脏X受体α依赖性脂肪生成基因诱导及肝脂肪变性中的作用
Hepatology. 2009 Jun;49(6):1913-25. doi: 10.1002/hep.22887.
9
GPR40 receptor activation promotes tight junction assembly in airway epithelial cells via AMPK-dependent mechanisms.GPR40受体激活通过AMPK依赖机制促进气道上皮细胞紧密连接组装。
Tissue Barriers. 2018;6(2):1-12. doi: 10.1080/21688370.2018.1480741. Epub 2018 Aug 29.
10
GW9508 ameliorates cognitive dysfunction via the external treatment of encephalopathy in Aβ induced mouse model of Alzheimer's disease.GW9508 通过对外科脑病的治疗改善 Aβ 诱导的阿尔茨海默病小鼠模型的认知功能障碍。
Eur J Pharmacol. 2021 Oct 15;909:174362. doi: 10.1016/j.ejphar.2021.174362. Epub 2021 Jul 21.

引用本文的文献

1
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis.综合筛查确定GPR31是代谢功能障碍相关脂肪性肝炎的关键驱动因素和可药物靶向目标。
J Clin Invest. 2025 Sep 2;135(17). doi: 10.1172/JCI173193.
2
HD6277 Suppresses Muscle Atrophy by Promoting Myogenic Factors and Inhibiting Proteolysis in Aged Mice.HD6277通过促进老年小鼠的生肌因子和抑制蛋白水解来抑制肌肉萎缩。
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13805. doi: 10.1002/jcsm.13805.
3
GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway.

本文引用的文献

1
Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway.游离脂肪酸受体1的激活通过一条p38依赖途径改善肝脂肪变性。
J Mol Endocrinol. 2014 Oct;53(2):165-74. doi: 10.1530/JME-14-0003. Epub 2014 Jul 9.
2
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.ω-3 脂肪酸通过抑制 NLRP3 炎性小体的激活来预防炎症和代谢紊乱。
Immunity. 2013 Jun 27;38(6):1154-63. doi: 10.1016/j.immuni.2013.05.015.
3
Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in the regulation of glucose homeostasis and insulin sensitivity.
GPR40 完全激动剂 AM1638 通过 AMPK 依赖性途径减轻棕榈酸酯诱导的 H9c2 细胞氧化损伤。
BMB Rep. 2025 Mar;58(3):133-139. doi: 10.5483/BMBRep.2024-0043.
4
Recent Developments in Drug Design of Oral Synthetic Free Fatty Acid Receptor 1 Agonists.口服合成游离脂肪酸受体1激动剂药物设计的最新进展
Drug Des Devel Ther. 2024 Dec 11;18:5961-5983. doi: 10.2147/DDDT.S487469. eCollection 2024.
5
GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice.GPR40/GPR120 激动剂 GW9508 改善代谢综合征加重的小鼠牙周炎。
Int J Mol Sci. 2024 Sep 5;25(17):9622. doi: 10.3390/ijms25179622.
6
Gene expression of free fatty acids-sensing G protein-coupled receptors in beef cattle.肉牛中游离脂肪酸感应G蛋白偶联受体的基因表达
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae114.
7
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates.参与代谢性疾病的 G 蛋白偶联受体:药物治疗开发的最新进展。
Acta Pharmacol Sin. 2024 Jul;45(7):1321-1336. doi: 10.1038/s41401-023-01215-2. Epub 2024 Feb 7.
8
Regulation and targeting of SREBP-1 in hepatocellular carcinoma.SREBP-1 在肝细胞癌中的调控和靶向治疗。
Cancer Metastasis Rev. 2024 Jun;43(2):673-708. doi: 10.1007/s10555-023-10156-5. Epub 2023 Dec 1.
9
AM1638, a GPR40-Full Agonist, Inhibited Palmitate- Induced ROS Production and Endoplasmic Reticulum Stress, Enhancing HUVEC Viability in an NRF2-Dependent Manner.AM1638,一种 GPR40 全激动剂,抑制棕榈酸诱导的 ROS 产生和内质网应激,以 NRF2 依赖的方式增强 HUVEC 活力。
Endocrinol Metab (Seoul). 2023 Dec;38(6):760-769. doi: 10.3803/EnM.2023.1774. Epub 2023 Nov 2.
10
Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies.含龙脑烯基的苄氧基苯基丙酸衍生物作为游离脂肪酸受体1激动剂的体外和体内研究
Pharmaceutics. 2023 Jun 7;15(6):1670. doi: 10.3390/pharmaceutics15061670.
选择性 G 蛋白偶联受体 40 激动剂 GW-9508 调节葡萄糖稳态和胰岛素敏感性的多种机制。
Am J Physiol Endocrinol Metab. 2013 Mar 15;304(6):E668-76. doi: 10.1152/ajpendo.00419.2012. Epub 2013 Jan 22.
4
AMPK: a nutrient and energy sensor that maintains energy homeostasis.AMPK:一种营养和能量传感器,可维持能量平衡。
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62. doi: 10.1038/nrm3311.
5
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.TAK-875 与安慰剂或格列美脲治疗 2 型糖尿病:一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2012 Apr 14;379(9824):1403-11. doi: 10.1016/S0140-6736(11)61879-5. Epub 2012 Feb 27.
6
n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.n-3脂肪酸可改善小鼠摄入LXR激动剂后的肝脏脂肪变性和功能障碍。
Biochim Biophys Acta. 2011 Sep;1811(9):491-7. doi: 10.1016/j.bbalip.2011.06.003. Epub 2011 Jun 13.
7
Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders.游离脂肪酸受体 FFAR1 和 GPR120 作为代谢紊乱的新型治疗靶点。
J Pharm Sci. 2011 Sep;100(9):3594-601. doi: 10.1002/jps.22639. Epub 2011 May 25.
8
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.AMPK 通过磷酸化和抑制 SREBP 的活性来减轻饮食诱导的胰岛素抵抗小鼠的肝脂肪变性和动脉粥样硬化。
Cell Metab. 2011 Apr 6;13(4):376-388. doi: 10.1016/j.cmet.2011.03.009.
9
Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.胰腺β细胞中GPR40的过表达增强葡萄糖刺激的胰岛素分泌,并改善正常和糖尿病小鼠的糖耐量。
Diabetes. 2009 May;58(5):1067-76. doi: 10.2337/db08-1233.
10
Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B.Cideb是一种与内质网和脂滴相关的蛋白质,它通过与载脂蛋白B相互作用来介导极低密度脂蛋白(VLDL)的脂化和成熟。
Cell Metab. 2009 Feb;9(2):177-90. doi: 10.1016/j.cmet.2008.12.013.